ArticleTrends in immunology2020
SARS Coronavirus Redux.
Article in Trends in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Article
- Site Density Functional Theory and Structural Bioinformatics Analysis of the SARS-CoV Spike Protein and hACE2 Complex.Molecules (Basel, Switzerland) · 2022Article
- An overview of viral mutagenesis and the impact on pathogenesis of SARS-CoV-2 variants.Frontiers in immunology · 2022Review
- Immunodominant linear B cell epitopes in the spike and membrane proteins of SARS-CoV-2 identified by immunoinformatics prediction and immunoassay.Scientific reports · 2021Article
- Molecular Determinants of SARS-CoV-2 Variants.Trends in microbiology · 2021Article
- Article
- Animal coronaviruses and SARS-CoV-2.Transboundary and emerging diseases · 2021Review
- Potential drug targets of SARS-CoV-2: From genomics to therapeutics.International journal of biological macromolecules · 2021Review
- DNA vaccines against COVID-19: Perspectives and challenges.Life sciences · 2021Review
- Review of COVID-19 and male genital tract.Andrologia · 2021Review
- COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention.Viruses · 2021Review
- Role of Serine Proteases and Host Cell Receptors Involved in Proteolytic Activation, Entry of SARS-CoV-2 and Its Current Therapeutic Options.Infection and drug resistance · 2021Review
- The epigenetic implication in coronavirus infection and therapy.Clinical epigenetics · 2020Review
- Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach.Biochimica et biophysica acta. Molecular basis of disease · 2020Review
- New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19?Cellular immunology · 2020Review
- Drug Discovery Strategies for SARS-CoV-2.The Journal of pharmacology and experimental therapeutics · 2020Review
- Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges.Life sciences · 2020Article
- The New Coronavirus (SARS-CoV-2): A Comprehensive Review on Immunity and the Application of Bioinformatics and Molecular Modeling to the Discovery of Potential Anti-SARS-CoV-2 Agents.Molecules (Basel, Switzerland) · 2020Review
- Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency.The Science of the total environment · 2020Review
- Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a newly emerged pathogen: an overview.Pathogens and disease · 2020Review
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
Abstract
As an atypical pneumonia began to appear in December 2019, Zhou et al. worked with remarkable speed to identify the associated virus, determine its relationship to animal viruses, and evaluate factors conferring infection susceptibility and resistance. These foundational results are being advanced to control the current worldwide human coronavirus epidemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.